Episode 441: The 2026 ACTRIMS Forum with Dr. Manuel Friese, Dr. Amit Bar-Or, and Dr. Haritha Desu

Last week, over 1,400 scientists and clinicians gathered in San Diego, California, at the 2026 Americas Committee for Treatment and Research in Multiple Sclerosis annual meeting, better known as the ACTRIMS Forum. This week, in Part One of our coverage, you'll hear from three of the experts who presented their research at the ACTRIMS Forum.

Dr. Manuel Friese, a clinician-scientist at the Institute of Neuroimmunology and Multiple Sclerosis at the University Medical Center Hamburg-Eppendorf in Hamburg, Germany, where he serves as the Director of the Center for Molecular Neurobiology, and the Director of the Institute of Neuroimmunology and Multiple Sclerosis, is this year's winner of the Barancik Prize for Innovation in Multiple Sclerosis. I had an opportunity to talk with Dr. Friese about some of his truly remarkable research.

Dr. Amit Bar-Or, the Director of the Centre for Neuroinflammation and Experimental Therapeutics (CNET) and Chief of the Division of Multiple Sclerosis (MS) and related disorders at the University of Pennsylvania, presented encouraging results from two important clinical trials. Dr. Bar-Or and I discussed what those results might mean for people living with relapsing-remitting and primary progressive MS.

Dr. Haritha Desu, a young investigator at the ACTRIMS Forum, presented her cutting-edge research on how immune cells interact with cells already resident in the brain to drive damage or potentially promote repair. I talked with Dr. Desu about how her work could be key to stopping MS progression independent of relapse activity.

We have a lot to talk about! Are you ready for RealTalk MS??!

This Week: The 2026 ACTRIMS Forum :22

Barancik Prize winner Dr. Manuel Friese discusses his pioneering discoveries 1:34

Dr. Amit Bar-Or shares encouraging results from two important clinical trials 16:27

Dr. Haritha Desu discusses her research 25:27

Share this episode 32:23

Next week's episode 32:42

SHARE THIS EPISODE OF REALTALK MS

Just copy this link & paste it into your text or email: https://realtalkms.com/441

ADD YOUR VOICE TO THE CONVERSATION

I've always thought about the RealTalk MS podcast as a conversation. And this is your opportunity to join the conversation by sharing your feedback, questions, and suggestions for topics that we can discuss in future podcast episodes. Please shoot me an email or call the RealTalk MS Listener Hotline and share your thoughts!

Email: jon@realtalkms.com
Phone: (310) 526-2283

And don't forget to join us in the RealTalk MS Facebook group!

LINKS

If your podcast app doesn't allow you to click on these links, you'll find them in the show notes in the RealTalk MS app or at www.RealTalkMS.com

Support Jon at WALK MS
https://realtalkms.com/walkms

Find out about ABLEnow Accounts
https://ablenow.com

JOIN: The RealTalk MS Facebook Group
https://facebook.com/groups/realtalkms

REVIEW: Give RealTalk MS a rating and review
http://www.realtalkms.com/review

Follow RealTalk MS on Twitter, @RealTalkMS_jon, and subscribe to our newsletter at our website, RealTalkMS.com.

RealTalk MS Episode 441
Guests: Dr. Manuel Friese, Dr. Amit Bar-Or, and Dr. Haritha Desu

Privacy Policy

Tämä jakso on lisätty Podme-palveluun avoimen RSS-syötteen kautta eikä se ole Podmen omaa tuotantoa. Siksi jakso saattaa sisältää mainontaa.

Jaksot(535)

Episode 481: It's Time to Update the Way We Describe MS with Dr. Peter Calabresi

The current clinical language used to describe multiple sclerosis hasn't kept pace with modern neuroscience—and clinging to outdated categories can stall treatment decisions, muddy research, and obscu...

9 Marras 31min

Episode 480: MSToronto 2026 with Dr. Jeffrey Cohen and Dr. Robert Fox

Our coverage of MSToronto 2026 continues this week with two important conversations. First, we'll hear from Dr. Jeffrey Cohen about the latest clinical findings on CAR-T cell therapy as a potential tr...

2 Marras 36min

Episode 479: From MSToronto 2026 with Dr. Bruce Bebo and Kristine Werner Ozug

Last week, about 8,000 MS researchers and clinicians arrived in Toronto, Canada, for MSToronto 2026, the joint meeting of the Americas Committee for Treatment and Research in MS and the European Commi...

29 Loka 45min

Episode 478: From MSToronto 2026 Patient Community Day with Professor Peter Feys and Karen Jacoby

Welcome to a special episode of RealTalk MS and The ECTRIMS Podcast! MS Toronto 2026 concluded with the event we were most looking forward to -- Patient Community Day -- where some of the top MS exper...

26 Loka 22min

Episode 477: One Year After CAR T-Cell Therapy with Jan Janisch-Hanzlik

Jan Janisch-Hanzlik was the first MS patient to receive CAR T-cell therapy as part of a clinical trial. We met Jan last year, in episode 424 of RealTalk MS, when she gave us a first-hand report on how...

19 Loka 30min

Episode 476: MS in the Workplace with Dana Foote

What happens when you're diagnosed with a chronic, unpredictable condition just as your career is taking off? That's exactly what happened to my guest, Dana Foote. This week, Dana joins us to sha...

12 Loka 36min

Episode 475: New Tools and Strategies for Managing MS-Related Cognitive Changes with Dr. Elizabeth Gromisch

Whether it's walking into a room and blanking on why you're there, struggling to pull up a word that's right on the tip of your tongue, or losing track of daily tasks, cognitive fatigue and brain fog ...

5 Loka 30min

Episode 474: The House That MS Built with Sarah Timmerman

Most people don't think about home accessibility until mobility changes force the conversation. But what if you decide to take control of the unknown and design your living space for whatever the futu...

28 Syys 25min